{"id":"W2890837529","doi":"10.1111/jdv.15242","title":"Long‐term safety profile of ixekizumab in patients with moderate‐to‐severe plaque psoriasis: an integrated analysis from 11 clinical trials","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Plaque psoriasis; Psoriasis; Clinical trial; Term (time); Safety profile; Dermatology; Internal medicine; Adverse effect; Psoriatic arthritis; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019423,0.0002605758,0.001736119,0.0004464335,0.0001064752,0.000005048098,0.00058215,0.0004743079,0.0001425886],"category_scores_gemma":[0.0003886702,0.0001534762,0.0003086156,0.0004283947,0.0007330904,0.0001269535,0.0001508506,0.0005482043,0.00001404243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002254027,"about_ca_system_score_gemma":0.00009109885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002684776,"about_ca_topic_score_gemma":0.0001151475,"domain_scores_codex":[0.9883865,0.008963264,0.001973575,0.000315581,0.00007220381,0.0002888362],"domain_scores_gemma":[0.9969875,0.0006805659,0.00181471,0.0002501401,0.0001941864,0.00007291874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01221624,0.0004891781,0.9624569,0.00001078417,0.003042449,0.00002047318,0.000480347,0.00002954757,0.0004122433,0.00009282271,0.0003066116,0.02044243],"study_design_scores_gemma":[0.008857134,0.0004227713,0.9808826,0.00009349626,0.001803021,0.0001863304,0.00007771394,0.000008766084,0.00702333,0.00008720889,0.0004019595,0.0001557079],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975803,0.0005239955,0.0002904748,0.0006126618,0.0004755302,0.0002505777,0.0001463022,0.000007595461,0.0001125033],"genre_scores_gemma":[0.9990441,0.0001344886,0.0003935708,0.0001995204,0.00009601776,0.000002131706,0.00005557764,0.00001878121,0.00005586536],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02028672,"threshold_uncertainty_score":0.6258578,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03878062737402969,"score_gpt":0.3123729353849405,"score_spread":0.2735923080109108,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}